• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Merit Medical Announces Process for Chief Executive Officer Succession Planning

    12/18/23 4:05:00 PM ET
    $MMSI
    Medical/Dental Instruments
    Health Care
    Get the next $MMSI alert in real time by email

    SOUTH JORDAN, Utah, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading global manufacturer and marketer of healthcare technology, today outlined the ongoing succession planning process for its Chief Executive Officer (CEO). Pursuant to an Amended and Restated Employment Agreement, effective June 8, 2023, Merit founder, CEO, and President, Fred Lampropoulos, will continue to serve as Merit's CEO and President through December 31, 2025.

    To carry out its responsibility for CEO succession, the Merit Board of Directors appointed a special steering committee of independent directors led by Ann Millner, Ed.D., Lead Independent Director. The committee is developing and providing oversight of a succession plan in preparation for Mr. Lampropoulos' retirement. The plan is also intended to prepare the company for a CEO transition at the appropriate time. Korn Ferry, a leading executive search firm, is currently assisting Merit's Board of Directors in the process of identifying potential internal and external candidates.

    "My fellow directors and I are committed to identifying a successor with the capabilities inherent to Merit's leadership requirements, including the ability to identify and pursue new strategic opportunities, attract and retain key talent, and build on the tradition of innovation that has been a hallmark of the company's success," said Dr. Millner. "We are focused on implementing a thoughtfully developed CEO succession plan that will maintain valued aspects of Merit's culture and position the company for future growth, development, and value creation."

    The company does not intend to provide further updates on the process until such time as a successor is designated.

    ABOUT MERIT MEDICAL Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of proprietary disposable medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Merit serves client hospitals worldwide with a domestic and international sales force and clinical support team totaling more than 700 individuals. Merit employs approximately 7,100 people worldwide. 

    TRADEMARKS Unless noted otherwise, trademarks and registered trademarks used in this release are the property of Merit Medical Systems, Inc., its subsidiaries, or its licensors.

    CONTACTS 

    PR/Media Inquiries 

    Sarah Comstock 

    Merit Medical 

    +1-801-432-2864 | sarah.comstock@merit.com 

    INVESTOR INQUIRIES 

    Mike Piccinino, CFA, IRC 

    ICR Westwicke

    +1-443-213-0509 | mike.piccinino@westwicke.com



    Primary Logo

    Get the next $MMSI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MMSI

    DatePrice TargetRatingAnalyst
    2/26/2026$78.00Overweight → Equal Weight
    Wells Fargo
    2/6/2026$107.00Buy
    BTIG Research
    3/28/2025$120.00Overweight
    Analyst
    12/11/2024$103.00 → $120.00Equal Weight → Overweight
    Wells Fargo
    6/28/2024$96.00Outperform
    Robert W. Baird
    4/11/2024$88.00Buy
    CL King
    2/7/2024$87.00Neutral
    BofA Securities
    12/21/2023$100.00Hold → Buy
    Canaccord Genuity
    More analyst ratings

    $MMSI
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    June 14, 2024 - FDA Roundup: June 14, 2024

    For Immediate Release: June 14, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA issued a proposed exemption for certain cottage cheese products from the requirements of the Food Traceability Rule. The proposal would exempt Grade “A” cottage cheese that appears on the Interstate Milk Shippers List from the requirements of the r

    6/14/24 3:54:45 PM ET
    $MMSI
    $BMY
    Medical/Dental Instruments
    Health Care
    Biotechnology: Pharmaceutical Preparations

    $MMSI
    SEC Filings

    View All

    SEC Form SD filed by Merit Medical Systems Inc.

    SD - MERIT MEDICAL SYSTEMS INC (0000856982) (Filer)

    5/29/26 4:10:07 PM ET
    $MMSI
    Medical/Dental Instruments
    Health Care

    Merit Medical Systems Inc. filed SEC Form 8-K: Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - MERIT MEDICAL SYSTEMS INC (0000856982) (Filer)

    5/19/26 4:54:43 PM ET
    $MMSI
    Medical/Dental Instruments
    Health Care

    SEC Form S-8 filed by Merit Medical Systems Inc.

    S-8 - MERIT MEDICAL SYSTEMS INC (0000856982) (Filer)

    5/15/26 4:06:33 PM ET
    $MMSI
    Medical/Dental Instruments
    Health Care

    $MMSI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Merit Medical Shareholders Elect Scott R. Ward to Board of Directors

    SOUTH JORDAN, Utah, May 19, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading global manufacturer and marketer of healthcare technology, today announced that shareholders elected Scott R. Ward to the company's Board of Directors at Merit's annual meeting of shareholders. Mr. Ward was elected to serve a three-year term. "On behalf of the Board, we are pleased with Scott Ward's election to Merit's Board of Directors," said F. Ann Millner, Merit's Chair of the Board. "Scott's extensive industry experience, strategic insight, and commitment to innovation will be tremendous assets as we continue advancing the company's strategic priorities." "We are proud to welco

    5/19/26 9:15:00 AM ET
    $MMSI
    Medical/Dental Instruments
    Health Care

    Merit Medical to Participate in the Bank of America Healthcare Conference

    SOUTH JORDAN, Utah, May 08, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading global manufacturer and marketer of healthcare technology, today announced that Merit management will participate in the Bank of America 2026 Health Care Conference, to be held in Las Vegas, Nevada, May 12-14, 2026. The management team will participate in a fireside chat session on Tuesday, May 12th at 3:00 pm Pacific Time / 6:00 pm Eastern Time. A live audio webcast of the fireside chat will be accessible under the "Events" section of the Company's investor relations website at Investor Events and Presentations - Merit Medical. A replay of the fireside chat will be available on this

    5/8/26 9:25:00 AM ET
    $MMSI
    Medical/Dental Instruments
    Health Care

    Merit Medical Reports First Quarter 2026 Results and Updates Full-Year Guidance

    Financial Highlights† Reported revenue of $381.9 million, up 7%Constant currency revenue* and constant currency revenue, organic* up 5% and up 3%, respectively Constant currency revenue, organic* increased 4%, excluding revenue from divested product line GAAP operating margin of 11.6%, compared to 11.5% in prior year periodNon-GAAP operating margin* of 19.7%, compared to 19.3% in prior year periodGAAP EPS $0.68, up 39%Non-GAAP EPS* $0.94, up 9%Free cash flow* generation of $24.7 million, up 26% Business Developments On February 17, 2026, Merit sold certain assets related to the DualCap® product line to Health Line International Corporation for a purchase price of $28 million, of which $25

    4/30/26 4:05:00 PM ET
    $MMSI
    Medical/Dental Instruments
    Health Care

    $MMSI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Merit Medical downgraded by Wells Fargo with a new price target

    Wells Fargo downgraded Merit Medical from Overweight to Equal Weight and set a new price target of $78.00

    2/26/26 7:10:22 AM ET
    $MMSI
    Medical/Dental Instruments
    Health Care

    BTIG Research initiated coverage on Merit Medical with a new price target

    BTIG Research initiated coverage of Merit Medical with a rating of Buy and set a new price target of $107.00

    2/6/26 7:51:56 AM ET
    $MMSI
    Medical/Dental Instruments
    Health Care

    Analyst initiated coverage on Merit Medical with a new price target

    Analyst initiated coverage of Merit Medical with a rating of Overweight and set a new price target of $120.00

    3/28/25 8:20:21 AM ET
    $MMSI
    Medical/Dental Instruments
    Health Care

    $MMSI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Commercial Officer Smith Christian Adam bought $99,186 worth of shares (1,626 units at $61.00) (SEC Form 4)

    4 - MERIT MEDICAL SYSTEMS INC (0000856982) (Issuer)

    5/13/26 1:19:17 PM ET
    $MMSI
    Medical/Dental Instruments
    Health Care

    CHIEF LEGAL OFFICER, SECRETARY Lloyd Brian G. bought $125,250 worth of shares (2,000 units at $62.62) (SEC Form 4)

    4 - MERIT MEDICAL SYSTEMS INC (0000856982) (Issuer)

    5/11/26 1:03:30 PM ET
    $MMSI
    Medical/Dental Instruments
    Health Care

    President and CEO Aronson Martha Goldberg bought $120,880 worth of shares (2,000 units at $60.44), increasing direct ownership by 4% to 49,792 units (SEC Form 4)

    4 - MERIT MEDICAL SYSTEMS INC (0000856982) (Issuer)

    5/7/26 4:12:26 PM ET
    $MMSI
    Medical/Dental Instruments
    Health Care

    $MMSI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Gunderson Thomas J. exercised 21,250 shares at a strike of $52.17, increasing direct ownership by 54% to 60,741 units (SEC Form 4)

    4 - MERIT MEDICAL SYSTEMS INC (0000856982) (Issuer)

    5/21/26 9:10:10 AM ET
    $MMSI
    Medical/Dental Instruments
    Health Care

    Director Ward Lynne N. was granted 3,457 shares, increasing direct ownership by 44% to 11,266 units (SEC Form 4)

    4 - MERIT MEDICAL SYSTEMS INC (0000856982) (Issuer)

    5/19/26 6:13:51 PM ET
    $MMSI
    Medical/Dental Instruments
    Health Care

    Director Ward Scott R. was granted 3,457 shares (SEC Form 4)

    4 - MERIT MEDICAL SYSTEMS INC (0000856982) (Issuer)

    5/19/26 6:12:38 PM ET
    $MMSI
    Medical/Dental Instruments
    Health Care

    $MMSI
    Financials

    Live finance-specific insights

    View All

    Merit Medical Reports First Quarter 2026 Results and Updates Full-Year Guidance

    Financial Highlights† Reported revenue of $381.9 million, up 7%Constant currency revenue* and constant currency revenue, organic* up 5% and up 3%, respectively Constant currency revenue, organic* increased 4%, excluding revenue from divested product line GAAP operating margin of 11.6%, compared to 11.5% in prior year periodNon-GAAP operating margin* of 19.7%, compared to 19.3% in prior year periodGAAP EPS $0.68, up 39%Non-GAAP EPS* $0.94, up 9%Free cash flow* generation of $24.7 million, up 26% Business Developments On February 17, 2026, Merit sold certain assets related to the DualCap® product line to Health Line International Corporation for a purchase price of $28 million, of which $25

    4/30/26 4:05:00 PM ET
    $MMSI
    Medical/Dental Instruments
    Health Care

    Merit Medical Systems to Announce First Quarter 2026 Results on April 30, 2026

    SOUTH JORDAN, Utah, April 02, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a global leader of healthcare technology, announced today that it will release its financial results for the quarter ended March 31, 2026, after the close of the stock market on Thursday, April 30, 2026. Merit plans to hold its investor conference call on the same day (Thursday, April 30, 2026) at 4:30 p.m. Eastern (3:30 p.m. Central, 2:30 p.m. Mountain, and 1:30 p.m. Pacific). To access the conference call, please pre-register using the following link. Registrants will receive confirmation with dial-in details. A live webcast and slide deck can be accessed using this link. A link to bo

    4/2/26 6:00:00 PM ET
    $MMSI
    Medical/Dental Instruments
    Health Care

    Merit Medical Acquires View Point Medical, Inc., expanding the Merit Therapeutic Oncology Portfolio

    SOUTH JORDAN, Utah, April 01, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a global leader of healthcare technology, today announced it has acquired View Point Medical, Inc. (View Point). Through a merger transaction, View Point is now a wholly-owned subsidiary of Merit. View Point, located in Carlsbad, California, manufactures the OneMark® Detection Imaging System and OneMark Tissue Markers. The aggregate transaction consideration, including the assumption of ViewPoint liabilities, is approximately $140 million. Of that amount, $90 million was paid in cash at closing and two deferred payments of $25 million each are scheduled to be paid not later than the first and

    4/1/26 9:15:00 AM ET
    $MMSI
    Medical/Dental Instruments
    Health Care

    $MMSI
    Leadership Updates

    Live Leadership Updates

    View All

    Merit Medical Shareholders Elect Scott R. Ward to Board of Directors

    SOUTH JORDAN, Utah, May 19, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading global manufacturer and marketer of healthcare technology, today announced that shareholders elected Scott R. Ward to the company's Board of Directors at Merit's annual meeting of shareholders. Mr. Ward was elected to serve a three-year term. "On behalf of the Board, we are pleased with Scott Ward's election to Merit's Board of Directors," said F. Ann Millner, Merit's Chair of the Board. "Scott's extensive industry experience, strategic insight, and commitment to innovation will be tremendous assets as we continue advancing the company's strategic priorities." "We are proud to welco

    5/19/26 9:15:00 AM ET
    $MMSI
    Medical/Dental Instruments
    Health Care

    Merit Medical Announces Resignation of President, Joseph Wright

    SOUTH JORDAN, Utah, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI) ("Merit" or the "Company"), a global leader of healthcare technology, today announced the resignation of its President, Joseph C. Wright, effective January 3, 2025. The Company noted that prior to Mr. Wright's resignation, Merit had received notice of allegations regarding his conduct, which Merit's independent directors investigated with the assistance of independent counsel. The allegations were unrelated to Merit's operations or financial performance. Based upon Mr. Wright's resignation, Merit's Board of Directors has re-appointed Fred P. Lampropoulos as Merit's President. ABOUT MERI

    12/16/24 4:00:00 PM ET
    $MMSI
    Medical/Dental Instruments
    Health Care

    Merit Medical Shareholders Elect Silvia M. Perez as New Director

    SOUTH JORDAN, Utah, May 16, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a global leader of healthcare technology, today announced that its shareholders elected Silvia M. Perez, President of the Commercial Branding and Transportation Division at 3M Company, as a director in Merit's Annual Meeting of Shareholders held on May 15, 2024. Merit's shareholders also re-elected Fred P. Lampropoulos and Stephen C. Evans as directors. Ms. Perez and Messrs. Lampropoulos and Evans were elected to serve three-year terms. "We are pleased to welcome Silvia Perez as our newest director," said Mr. Lampropoulos, Merit's Chairman and Chief Executive Officer. "Her expertise and proven

    5/16/24 4:05:00 PM ET
    $MMSI
    Medical/Dental Instruments
    Health Care

    $MMSI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Merit Medical Systems Inc.

    SC 13G/A - MERIT MEDICAL SYSTEMS INC (0000856982) (Subject)

    11/14/24 11:05:03 AM ET
    $MMSI
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Merit Medical Systems Inc. (Amendment)

    SC 13G/A - MERIT MEDICAL SYSTEMS INC (0000856982) (Subject)

    2/13/24 5:09:38 PM ET
    $MMSI
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Merit Medical Systems Inc. (Amendment)

    SC 13G/A - MERIT MEDICAL SYSTEMS INC (0000856982) (Subject)

    2/12/24 5:32:43 PM ET
    $MMSI
    Medical/Dental Instruments
    Health Care